|
Model Number VS-404 |
Device Problem
Biocompatibility (2886)
|
Patient Problems
Erythema (1840); Unspecified Infection (1930); Pain (1994); Phlebitis (2004); Ulcer (2274); Thrombosis/Thrombus (4440); Swelling/ Edema (4577)
|
Event Date 05/17/2022 |
Event Type
Injury
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
A physician used venaseal closure system to treat an active venous leg ulcer with reflux present in the great saphenous vein, perforator, and probably the deep venous system of a patient (the physician did not check the deep system).The ifu was followed during preparation, procedure, post-procedure.A guidewire was used for the insertion of the catheter.The lumen was flushed prior to use.Local anesthesia was used.The procedure was successfully completed per ifu.No additional treatment was required.The vein closed with 60cm treated.2 weeks post venaseal treatment the patient is experiencing discomfort, severe pain and edema in the treated leg.Bright erythema changes overlining the vein is observed.The physician treated the patient based on thromobophlebitis then the wounds opened up (blistered up) and new ulcer developed.Patient is treated/managed with antibiotics and steroids and can walk now with cane assistance.The patient has been sent to the wound clinic to get wounds debride.Infection and allergy testing were not done at this time.Physician was notified that the patient was admitted to the hospital with a septic infection and managed with iv antibiotics.The patient tested positive for staph, mssa specifically, and is in considerable amount of pain.No further injury reported.
|
|
Manufacturer Narrative
|
Image analysis:two images were provided for evaluation.In both images you can see the patients leg, an open sore can be observed on the patients leg.There is no indication from the images attached that the vena seal device caused the open wound on the patients leg.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|